| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0390 |
Trauma response team associated with hospital critical care service |
3,980 |
3,874 |
$46.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
122,675 |
113,703 |
$35.15M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
66,578 |
55,889 |
$26.30M |
| 0450 |
Emergency room services |
16,579 |
14,567 |
$7.76M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
89,343 |
87,743 |
$6.71M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
91,953 |
74,779 |
$4.11M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,153 |
2,165 |
$2.76M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
33,916 |
33,520 |
$2.00M |
| 0762 |
|
2,552 |
1,201 |
$1.98M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
22,687 |
21,796 |
$1.62M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,620 |
1,120 |
$1.52M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
11,543 |
11,400 |
$1.22M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
29,278 |
15,609 |
$1.16M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
542 |
395 |
$1.16M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,470 |
1,061 |
$1.06M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
9,063 |
6,254 |
$1.06M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,923 |
17,864 |
$789K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
37,436 |
36,763 |
$767K |
| 76818 |
|
18,686 |
9,093 |
$752K |
| 88307 |
|
9,878 |
9,764 |
$670K |
| 80053 |
Comprehensive metabolic panel |
92,329 |
85,813 |
$660K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,508 |
18,503 |
$638K |
| 84443 |
Thyroid stimulating hormone (TSH) |
49,472 |
48,129 |
$595K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,235 |
840 |
$595K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14,239 |
14,010 |
$589K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,751 |
6,584 |
$565K |
| 99233 |
Prolong inpt eval add15 m |
13,276 |
7,036 |
$558K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
127,809 |
114,256 |
$506K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16,457 |
15,540 |
$505K |
| 70450 |
Computed tomography, head or brain; without contrast material |
21,263 |
20,075 |
$498K |
| 80061 |
Lipid panel |
46,158 |
45,283 |
$452K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,204 |
6,108 |
$425K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
669 |
643 |
$422K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58,178 |
56,625 |
$415K |
| 99460 |
|
7,110 |
7,045 |
$408K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,960 |
11,071 |
$386K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
24,948 |
24,472 |
$383K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18,529 |
18,001 |
$374K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18,525 |
17,999 |
$372K |
| 86480 |
|
11,272 |
11,086 |
$370K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
26,780 |
21,670 |
$343K |
| 71045 |
Radiologic examination, chest; single view |
58,491 |
46,852 |
$337K |
| 99070 |
|
105,355 |
54,708 |
$330K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,706 |
5,630 |
$328K |
| 99223 |
Prolong inpt eval add15 m |
3,965 |
3,877 |
$320K |
| 99222 |
Initial hospital care, per day, moderate complexity |
4,098 |
4,043 |
$316K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
9,455 |
9,173 |
$298K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13,741 |
13,423 |
$275K |
| 71046 |
Radiologic examination, chest; 2 views |
33,660 |
32,370 |
$274K |
| Z1034 |
|
5,027 |
3,798 |
$255K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
50,430 |
44,393 |
$247K |
| 86171 |
|
17,051 |
16,005 |
$239K |
| 80074 |
|
7,132 |
7,027 |
$238K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
8,494 |
6,004 |
$238K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
155 |
141 |
$205K |
| 84439 |
|
31,322 |
30,500 |
$199K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,988 |
1,967 |
$196K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,012 |
985 |
$196K |
| 86331 |
|
17,089 |
16,035 |
$192K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,276 |
3,158 |
$173K |
| 76770 |
|
4,387 |
4,343 |
$167K |
| Q3014 |
Telehealth originating site facility fee |
6,936 |
6,368 |
$166K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,882 |
7,674 |
$164K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,631 |
5,578 |
$163K |
| 86003 |
|
1,531 |
1,374 |
$160K |
| 86780 |
|
19,307 |
17,850 |
$153K |
| 77066 |
Tomosynthesis, mammo |
1,611 |
1,544 |
$149K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,552 |
5,710 |
$144K |
| 86803 |
|
14,732 |
14,527 |
$136K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,360 |
10,536 |
$136K |
| 76642 |
|
2,706 |
2,594 |
$129K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
31,196 |
28,125 |
$128K |
| 95720 |
|
663 |
369 |
$127K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,066 |
1,987 |
$121K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,272 |
9,034 |
$114K |
| 76801 |
|
3,305 |
3,110 |
$111K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
837 |
784 |
$111K |
| 71250 |
|
1,418 |
1,390 |
$105K |
| 74178 |
|
456 |
452 |
$98K |
| 87536 |
|
1,618 |
1,576 |
$97K |
| 76641 |
|
1,876 |
1,857 |
$96K |
| 86235 |
|
4,157 |
3,928 |
$94K |
| 81001 |
|
68,013 |
61,869 |
$93K |
| 99243 |
|
1,610 |
1,525 |
$92K |
| 94729 |
|
2,918 |
2,885 |
$92K |
| 76830 |
Ultrasound, transvaginal |
2,526 |
2,454 |
$92K |
| 87340 |
|
11,626 |
11,354 |
$90K |
| 80076 |
|
23,697 |
21,850 |
$90K |
| 94726 |
|
2,894 |
2,862 |
$89K |
| 0710 |
|
7,213 |
6,120 |
$87K |
| 59025 |
Fetal non-stress test |
7,942 |
5,594 |
$87K |
| 87522 |
Neg quan hep c or qual rna |
2,448 |
2,377 |
$85K |
| 82570 |
|
21,281 |
20,126 |
$85K |
| 94060 |
|
3,074 |
3,030 |
$84K |
| 83970 |
|
2,933 |
2,852 |
$84K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,580 |
1,550 |
$81K |
| 82043 |
|
18,416 |
17,858 |
$79K |
| 99462 |
|
2,749 |
2,362 |
$78K |
| 97597 |
|
1,497 |
962 |
$73K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
7,292 |
7,111 |
$73K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
23,875 |
20,744 |
$70K |
| 88304 |
|
3,317 |
3,175 |
$66K |
| 73110 |
|
6,702 |
5,690 |
$63K |
| 82728 |
|
6,189 |
5,978 |
$62K |
| 99464 |
|
808 |
798 |
$61K |
| 82105 |
|
2,933 |
2,795 |
$61K |
| 73630 |
|
7,531 |
6,505 |
$61K |
| 99215 |
Prolong outpt/office vis |
854 |
832 |
$59K |
| 77065 |
Tomosynthesis, mammo |
783 |
767 |
$59K |
| 73130 |
|
8,336 |
7,209 |
$59K |
| 86140 |
|
16,686 |
15,917 |
$58K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,857 |
2,539 |
$58K |
| 73610 |
|
7,348 |
6,516 |
$58K |
| 90791 |
Psychiatric diagnostic evaluation |
358 |
349 |
$58K |
| 83880 |
|
4,227 |
3,920 |
$57K |
| 73562 |
|
8,036 |
6,931 |
$55K |
| 76536 |
|
1,479 |
1,463 |
$54K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
2,028 |
810 |
$51K |
| 72100 |
|
3,471 |
3,377 |
$51K |
| 86762 |
|
4,665 |
4,544 |
$51K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,442 |
1,345 |
$50K |
| 0510 |
|
2,066 |
1,914 |
$50K |
| 83735 |
|
22,192 |
17,444 |
$49K |
| 99152 |
|
1,392 |
1,315 |
$48K |
| 86317 |
|
7,855 |
7,732 |
$48K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,452 |
1,402 |
$48K |
| 85610 |
|
24,338 |
20,799 |
$47K |
| 73030 |
|
5,434 |
4,850 |
$47K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
442 |
428 |
$45K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,283 |
1,282 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,543 |
5,110 |
$44K |
| 88312 |
|
2,579 |
2,498 |
$44K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
122 |
121 |
$43K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
430 |
423 |
$43K |
| 86255 |
|
4,451 |
4,290 |
$42K |
| 80299 |
|
3,248 |
2,962 |
$42K |
| 85730 |
|
18,266 |
16,686 |
$42K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
343 |
336 |
$42K |
| 70486 |
|
1,317 |
1,274 |
$41K |
| 83550 |
|
7,078 |
6,879 |
$41K |
| 20680 |
|
23 |
12 |
$40K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
339 |
333 |
$40K |
| 90674 |
|
920 |
911 |
$38K |
| 95700 |
|
168 |
166 |
$38K |
| 83540 |
|
8,074 |
7,756 |
$38K |
| 86160 |
|
3,062 |
2,969 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
714 |
709 |
$37K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
778 |
752 |
$34K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21,520 |
18,329 |
$34K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,635 |
9,369 |
$33K |
| 82607 |
|
3,245 |
3,167 |
$33K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,500 |
1,483 |
$32K |
| 87186 |
|
7,000 |
6,214 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,235 |
1,318 |
$30K |
| 85652 |
|
16,024 |
15,317 |
$29K |
| 84100 |
|
19,635 |
15,887 |
$29K |
| 74018 |
|
4,114 |
3,439 |
$29K |
| 84153 |
|
4,730 |
4,571 |
$29K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
442 |
412 |
$29K |
| 87529 |
|
913 |
911 |
$28K |
| 86704 |
|
4,372 |
4,312 |
$27K |
| 93351 |
|
187 |
187 |
$27K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
568 |
390 |
$26K |
| 93970 |
|
433 |
420 |
$26K |
| 86360 |
|
1,149 |
1,111 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,207 |
13,011 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,082 |
13,532 |
$25K |
| 85018 |
|
14,136 |
13,860 |
$25K |
| 90739 |
|
217 |
215 |
$25K |
| 25600 |
|
285 |
267 |
$25K |
| 93971 |
|
1,297 |
1,260 |
$25K |
| 95718 |
|
210 |
208 |
$25K |
| 85027 |
|
6,623 |
5,837 |
$24K |
| 99381 |
|
212 |
212 |
$24K |
| 82378 |
|
1,693 |
1,419 |
$24K |
| 86708 |
|
3,307 |
3,273 |
$23K |
| 86039 |
|
3,459 |
3,386 |
$23K |
| 83690 |
|
19,022 |
17,313 |
$23K |
| 86038 |
|
7,822 |
7,568 |
$23K |
| 0001A |
|
619 |
619 |
$23K |
| 86200 |
|
2,959 |
2,915 |
$23K |
| 87077 |
|
5,482 |
5,222 |
$22K |
| 73590 |
|
3,646 |
3,174 |
$22K |
| 84702 |
|
4,572 |
3,361 |
$22K |
| 73080 |
|
2,451 |
2,245 |
$21K |
| 99254 |
|
280 |
277 |
$21K |
| 95886 |
|
368 |
360 |
$21K |
| 86901 |
|
13,612 |
12,700 |
$21K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
920 |
917 |
$21K |
| 86850 |
|
11,950 |
11,263 |
$21K |
| 81025 |
|
22,434 |
20,516 |
$20K |
| 0370 |
|
7,475 |
3,204 |
$20K |
| 83655 |
|
4,574 |
4,427 |
$20K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
64 |
64 |
$20K |
| 82247 |
|
5,402 |
3,724 |
$20K |
| 82950 |
|
5,198 |
5,077 |
$19K |
| 76857 |
|
905 |
855 |
$19K |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
190 |
188 |
$19K |
| 86592 |
|
7,509 |
7,302 |
$18K |
| 86021 |
|
1,303 |
1,264 |
$18K |
| 0002A |
|
437 |
437 |
$17K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,021 |
3,642 |
$17K |
| 82397 |
|
1,255 |
1,230 |
$17K |
| 90662 |
|
185 |
184 |
$17K |
| 0760 |
|
932 |
784 |
$17K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,049 |
798 |
$17K |
| 86431 |
|
3,911 |
3,848 |
$17K |
| 83883 |
|
1,056 |
1,007 |
$17K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,543 |
1,020 |
$16K |
| 72040 |
|
1,044 |
1,012 |
$15K |
| 84154 |
|
3,665 |
3,580 |
$15K |
| 90715 |
|
3,717 |
3,593 |
$15K |
| 70498 |
|
380 |
379 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,839 |
9,313 |
$15K |
| 82746 |
|
1,297 |
1,280 |
$14K |
| 86705 |
|
1,498 |
1,490 |
$14K |
| 83001 |
|
951 |
937 |
$13K |
| 82951 |
|
1,209 |
1,188 |
$13K |
| 84403 |
|
1,984 |
1,910 |
$13K |
| 77080 |
|
298 |
294 |
$13K |
| 86900 |
|
7,284 |
7,027 |
$12K |
| 90686 |
|
728 |
598 |
$12K |
| 73120 |
|
1,136 |
649 |
$12K |
| 73502 |
|
856 |
790 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
208 |
202 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
896 |
807 |
$12K |
| 82731 |
|
500 |
476 |
$11K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
610 |
607 |
$11K |
| 99253 |
|
212 |
208 |
$11K |
| 83516 |
|
812 |
604 |
$11K |
| 93271 |
|
146 |
145 |
$11K |
| 84146 |
|
748 |
740 |
$11K |
| 86812 |
|
814 |
805 |
$11K |
| 73090 |
|
2,284 |
1,954 |
$10K |
| 82248 |
|
2,848 |
2,013 |
$10K |
| 83615 |
|
2,560 |
2,351 |
$10K |
| 84550 |
|
3,156 |
3,048 |
$10K |
| 73560 |
|
886 |
660 |
$10K |
| 90694 |
|
115 |
115 |
$10K |
| 83002 |
|
684 |
673 |
$9K |
| 45390 |
|
54 |
46 |
$9K |
| 76000 |
|
1,518 |
1,118 |
$9K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,762 |
1,312 |
$9K |
| 73221 |
|
73 |
70 |
$9K |
| 95713 |
|
13 |
13 |
$9K |
| 82565 |
|
2,463 |
2,406 |
$9K |
| 86225 |
|
1,605 |
1,585 |
$9K |
| 84480 |
|
1,834 |
1,774 |
$9K |
| 12002 |
|
1,056 |
1,032 |
$9K |
| 93270 |
|
283 |
282 |
$9K |
| 88302 |
|
501 |
486 |
$9K |
| 82785 |
|
1,276 |
1,254 |
$9K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
128 |
121 |
$9K |
| 84156 |
|
3,087 |
2,773 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14,318 |
10,243 |
$9K |
| 99463 |
|
80 |
80 |
$9K |
| 73700 |
|
201 |
194 |
$9K |
| 87109 |
|
670 |
602 |
$8K |
| 95911 |
|
82 |
80 |
$8K |
| 82330 |
|
909 |
877 |
$8K |
| 82948 |
|
14,653 |
11,573 |
$8K |
| 86376 |
|
1,005 |
999 |
$8K |
| 20550 |
|
191 |
171 |
$8K |
| 70496 |
|
123 |
123 |
$8K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
235 |
232 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,430 |
12,836 |
$8K |
| 83010 |
|
746 |
716 |
$8K |
| 86706 |
|
1,977 |
1,948 |
$8K |
| 76870 |
|
348 |
339 |
$8K |
| 82977 |
|
2,266 |
2,142 |
$7K |
| 81003 |
|
4,923 |
3,909 |
$7K |
| 73564 |
|
690 |
621 |
$7K |
| P9011 |
Blood, split unit |
5,385 |
4,938 |
$7K |
| 72170 |
|
2,062 |
1,994 |
$7K |
| 82533 |
|
603 |
570 |
$7K |
| 88300 |
|
1,363 |
1,308 |
$7K |
| 84445 |
|
243 |
237 |
$7K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
120 |
94 |
$7K |
| 82150 |
|
1,507 |
1,433 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,620 |
3,603 |
$7K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,449 |
1,344 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,264 |
2,187 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,839 |
2,885 |
$7K |
| J3490 |
Unclassified drugs |
13,082 |
7,126 |
$7K |
| 82172 |
|
470 |
460 |
$7K |
| 84402 |
|
1,165 |
1,145 |
$7K |
| 95951 |
|
30 |
12 |
$6K |
| 96127 |
|
1,662 |
1,598 |
$6K |
| 99245 |
|
52 |
52 |
$6K |
| V5008 |
Hearing screening |
204 |
187 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,773 |
10,572 |
$6K |
| 87210 |
|
5,631 |
5,288 |
$6K |
| 25605 |
|
58 |
53 |
$6K |
| 20605 |
|
164 |
152 |
$6K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
18 |
18 |
$6K |
| 99606 |
|
377 |
350 |
$6K |
| 83519 |
|
409 |
400 |
$5K |
| 86695 |
|
1,419 |
876 |
$5K |
| 84484 |
|
9,184 |
8,023 |
$5K |
| 86696 |
|
1,417 |
875 |
$5K |
| 80055 |
|
174 |
157 |
$5K |
| 82784 |
|
761 |
730 |
$5K |
| 93000 |
|
253 |
251 |
$5K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
12 |
12 |
$5K |
| 82550 |
|
2,733 |
2,474 |
$5K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
669 |
139 |
$5K |
| 87088 |
|
1,412 |
1,000 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,889 |
4,345 |
$5K |
| 87070 |
|
2,032 |
1,848 |
$5K |
| 73100 |
|
445 |
254 |
$5K |
| 84481 |
|
967 |
949 |
$5K |
| 45384 |
|
13 |
12 |
$4K |
| 96156 |
|
92 |
92 |
$4K |
| 86800 |
|
745 |
728 |
$4K |
| 88108 |
|
206 |
193 |
$4K |
| 99205 |
Prolong outpt/office vis |
44 |
44 |
$4K |
| 95714 |
|
15 |
12 |
$4K |
| 95861 |
|
158 |
155 |
$4K |
| 70491 |
|
65 |
65 |
$4K |
| 90677 |
|
12 |
12 |
$4K |
| 82947 |
|
1,317 |
1,185 |
$4K |
| 86300 |
|
448 |
271 |
$4K |
| 73552 |
|
562 |
471 |
$4K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
116 |
30 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,955 |
2,190 |
$4K |
| 82672 |
|
205 |
203 |
$4K |
| 17250 |
|
182 |
97 |
$4K |
| 86301 |
|
484 |
447 |
$4K |
| 85014 |
|
1,958 |
1,906 |
$3K |
| 84703 |
|
2,321 |
2,097 |
$3K |
| 93308 |
|
467 |
464 |
$3K |
| 86341 |
|
109 |
71 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,699 |
5,001 |
$3K |
| 90744 |
|
340 |
338 |
$3K |
| 83525 |
|
451 |
380 |
$3K |
| 83520 |
|
2,560 |
2,040 |
$3K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
2,338 |
2,274 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,166 |
1,332 |
$3K |
| 87081 |
|
586 |
563 |
$3K |
| 73140 |
|
391 |
337 |
$3K |
| 84157 |
|
1,244 |
699 |
$3K |
| 80069 |
|
409 |
380 |
$3K |
| 99255 |
|
31 |
30 |
$3K |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
67 |
66 |
$3K |
| 89051 |
|
1,580 |
960 |
$3K |
| 82272 |
|
1,670 |
1,637 |
$3K |
| 99153 |
Mod sedat endo service >5yrs |
2,230 |
2,063 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
65 |
49 |
$2K |
| 82627 |
|
343 |
341 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,013 |
1,164 |
$2K |
| 84165 |
|
704 |
666 |
$2K |
| 99221 |
|
56 |
56 |
$2K |
| 86304 |
|
319 |
276 |
$2K |
| 90670 |
|
250 |
248 |
$2K |
| 87102 |
|
377 |
307 |
$2K |
| 84425 |
|
247 |
243 |
$2K |
| 84460 |
|
464 |
453 |
$2K |
| 0004A |
|
57 |
57 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
5,466 |
4,693 |
$2K |
| 90647 |
|
222 |
221 |
$2K |
| 84155 |
|
705 |
668 |
$2K |
| 72070 |
|
116 |
116 |
$2K |
| 12001 |
|
1,179 |
1,133 |
$2K |
| 99465 |
|
12 |
12 |
$2K |
| 96367 |
|
453 |
406 |
$2K |
| 26600 |
|
12 |
12 |
$2K |
| 73060 |
|
274 |
233 |
$2K |
| 86593 |
|
1,266 |
1,090 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
13 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
3,871 |
3,003 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
199 |
156 |
$2K |
| 99384 |
|
12 |
12 |
$2K |
| 80177 |
|
147 |
144 |
$2K |
| 88311 |
|
300 |
298 |
$2K |
| 90723 |
|
175 |
175 |
$2K |
| 82670 |
|
176 |
171 |
$2K |
| 29125 |
|
514 |
496 |
$2K |
| 87205 |
|
1,299 |
1,130 |
$2K |
| 85379 |
|
923 |
893 |
$2K |
| 90680 |
|
166 |
166 |
$2K |
| 86256 |
|
149 |
148 |
$1K |
| 85613 |
|
155 |
141 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
66 |
66 |
$1K |
| 82024 |
|
154 |
148 |
$1K |
| 92551 |
|
269 |
268 |
$1K |
| 84432 |
|
213 |
209 |
$1K |
| 93017 |
|
26 |
24 |
$1K |
| 76604 |
|
114 |
113 |
$1K |
| 86334 |
|
136 |
129 |
$1K |
| 82390 |
|
205 |
203 |
$1K |
| 0031A |
|
34 |
34 |
$1K |
| 85045 |
|
433 |
396 |
$1K |
| 87040 |
|
2,286 |
1,661 |
$1K |
| 95812 |
|
31 |
29 |
$1K |
| 92650 |
|
41 |
41 |
$1K |
| 73000 |
|
136 |
111 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
247 |
247 |
$1K |
| 82040 |
|
325 |
312 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,602 |
1,420 |
$1K |
| 82140 |
|
244 |
222 |
$1K |
| 84681 |
|
144 |
140 |
$1K |
| 28470 |
|
45 |
44 |
$1K |
| 83605 |
|
4,384 |
3,647 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
43 |
43 |
$1K |
| 86580 |
|
293 |
249 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
195 |
181 |
$1K |
| 92134 |
|
32 |
32 |
$983.73 |
| 92228 |
|
46 |
46 |
$960.90 |
| 88342 |
|
25 |
24 |
$944.20 |
| 82945 |
|
387 |
334 |
$921.89 |
| 90746 |
|
12 |
12 |
$906.27 |
| 73620 |
|
93 |
67 |
$888.62 |
| 93272 |
|
40 |
40 |
$878.95 |
| 26720 |
|
34 |
34 |
$850.00 |
| 97802 |
|
12 |
12 |
$847.83 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
429 |
388 |
$843.77 |
| 90633 |
|
89 |
89 |
$841.05 |
| 0054A |
|
21 |
21 |
$840.00 |
| 99241 |
|
29 |
29 |
$836.75 |
| 84436 |
|
193 |
189 |
$836.17 |
| 92015 |
Determination of refractive state |
214 |
214 |
$803.76 |
| 82952 |
|
265 |
255 |
$760.23 |
| 29515 |
|
200 |
194 |
$757.16 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
12 |
12 |
$732.59 |
| 86146 |
|
25 |
25 |
$724.56 |
| 12011 |
|
430 |
420 |
$720.75 |
| 83498 |
|
49 |
49 |
$714.53 |
| 99242 |
|
13 |
13 |
$702.14 |
| 86870 |
|
28 |
25 |
$698.55 |
| 29075 |
|
28 |
28 |
$680.25 |
| J1815 |
Injection, insulin, per 5 units |
564 |
324 |
$658.56 |
| 86923 |
|
134 |
113 |
$636.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,081 |
3,282 |
$590.16 |
| 90649 |
|
59 |
59 |
$557.55 |
| 82747 |
|
129 |
128 |
$548.72 |
| 72202 |
|
54 |
54 |
$529.94 |
| Z1038 |
|
12 |
12 |
$526.84 |
| 84166 |
|
132 |
131 |
$516.94 |
| 90710 |
|
54 |
54 |
$510.30 |
| 99188 |
|
52 |
52 |
$504.90 |
| 92558 |
|
16 |
16 |
$504.00 |
| 86008 |
|
14 |
14 |
$503.72 |
| 90700 |
|
51 |
51 |
$481.95 |
| 84270 |
|
44 |
42 |
$458.45 |
| 74220 |
|
14 |
13 |
$452.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
567 |
458 |
$448.07 |
| 93880 |
|
14 |
14 |
$437.27 |
| 88104 |
|
28 |
28 |
$433.86 |
| 87338 |
|
42 |
41 |
$422.74 |
| 86709 |
|
49 |
49 |
$402.95 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
347 |
227 |
$346.62 |
| 72046 |
|
19 |
19 |
$342.90 |
| 73070 |
|
50 |
39 |
$328.34 |
| 73600 |
|
23 |
13 |
$305.97 |
| 81002 |
|
1,058 |
957 |
$304.23 |
| 86671 |
|
12 |
12 |
$300.61 |
| 80143 |
|
1,273 |
1,214 |
$295.38 |
| J1630 |
Injection, haloperidol, up to 5 mg |
616 |
565 |
$293.88 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
42 |
12 |
$284.66 |
| J2060 |
Injection, lorazepam, 2 mg |
1,631 |
1,389 |
$271.33 |
| 10060 |
|
485 |
427 |
$266.81 |
| 80164 |
|
62 |
51 |
$258.74 |
| 83993 |
|
14 |
14 |
$251.28 |
| 86335 |
|
27 |
26 |
$244.57 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,613 |
1,555 |
$244.34 |
| 90734 |
|
25 |
25 |
$236.25 |
| 84630 |
|
25 |
25 |
$222.39 |
| 84244 |
|
18 |
12 |
$219.35 |
| 82103 |
|
27 |
26 |
$219.11 |
| 86787 |
|
44 |
44 |
$218.38 |
| 80179 |
|
819 |
806 |
$215.63 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
30 |
30 |
$197.53 |
| 84145 |
|
243 |
238 |
$195.66 |
| J7050 |
Infusion, normal saline solution, 250 cc |
39 |
32 |
$194.34 |
| 80189 |
|
12 |
12 |
$192.49 |
| A4217 |
Sterile water/saline, 500 ml |
628 |
543 |
$189.70 |
| 83930 |
|
43 |
38 |
$179.54 |
| 92552 |
|
12 |
12 |
$158.64 |
| 86753 |
|
12 |
12 |
$158.53 |
| 82239 |
|
33 |
25 |
$157.33 |
| 97750 |
|
877 |
522 |
$135.42 |
| 76937 |
|
36 |
34 |
$134.61 |
| 82010 |
|
734 |
683 |
$127.80 |
| 84466 |
|
26 |
26 |
$121.71 |
| J1644 |
Injection, heparin sodium, per 1000 units |
254 |
115 |
$121.40 |
| 76775 |
|
12 |
12 |
$108.65 |
| J1940 |
Injection, furosemide, up to 20 mg |
65 |
55 |
$108.22 |
| 84300 |
|
43 |
41 |
$107.57 |
| 74022 |
|
117 |
104 |
$105.88 |
| 87045 |
|
12 |
12 |
$102.17 |
| 81000 |
|
48 |
48 |
$98.98 |
| 73020 |
|
15 |
14 |
$92.55 |
| 84133 |
|
41 |
39 |
$87.77 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
113 |
95 |
$86.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
319 |
314 |
$85.15 |
| 83935 |
|
15 |
15 |
$81.87 |
| 82803 |
|
202 |
187 |
$79.41 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
743 |
455 |
$78.54 |
| 80329 |
|
243 |
225 |
$75.96 |
| 82085 |
|
12 |
12 |
$71.64 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
94 |
63 |
$69.02 |
| 99607 |
|
41 |
41 |
$66.00 |
| 90673 |
|
140 |
140 |
$62.78 |
| 92133 |
|
17 |
16 |
$62.08 |
| 83021 |
|
12 |
12 |
$58.37 |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
2,956 |
2,144 |
$44.67 |
| 36000 |
|
36 |
34 |
$34.16 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
233 |
191 |
$26.10 |
| 0250 |
|
355 |
160 |
$21.69 |
| 92020 |
|
14 |
14 |
$17.29 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
211 |
203 |
$15.78 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
426 |
262 |
$11.40 |
| 87807 |
|
51 |
50 |
$7.20 |
| 0270 |
|
25 |
25 |
$0.30 |
| 3079F |
|
217 |
193 |
$0.00 |
| 3074F |
|
720 |
613 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
146 |
146 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
24 |
24 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
50 |
45 |
$0.00 |
| 3075F |
|
29 |
25 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
55 |
39 |
$0.00 |
| 99156 |
|
28 |
27 |
$0.00 |
| 0258 |
|
22 |
13 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| 3078F |
|
634 |
540 |
$0.00 |
| 3077F |
|
104 |
92 |
$0.00 |
| 51702 |
|
15 |
12 |
$0.00 |
| 99173 |
|
39 |
39 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
41 |
37 |
$0.00 |
| 99157 |
|
26 |
26 |
$0.00 |
| 0272 |
|
25 |
15 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
13 |
13 |
$0.00 |